Related Experiment Videos
Hypertension and the J-curve. How low should you go?
1University of British Columbia, Vancouver.
Insights
The controversial "J-curve" effect in blood pressure treatment, where low diastolic pressures below 80 mm Hg may increase cardiac events, is examined. This analysis explores both sides of the debate to suggest balanced treatment targets.
Area of Science:
- Cardiology
- Hypertension Management
- Clinical Pharmacology
Background:
- The "J-curve" phenomenon suggests increased cardiovascular events at low diastolic blood pressure (DBP) after treatment.
- This controversial hypothesis challenges traditional hypertension treatment goals.
- Evidence supporting and refuting the J-curve effect requires critical evaluation.
Purpose of the Study:
- To critically examine the evidence for and against the "J-curve" phenomenon in treated hypertension.
- To evaluate the association between low diastolic blood pressure and adverse cardiovascular outcomes.
- To propose a balanced approach for setting blood pressure treatment targets.
Main Methods:
- Systematic review of recent analyses on treated blood pressure and clinical events.
- Comparative analysis of studies supporting the "J-curve" hypothesis.
- Examination of studies refuting the association between low DBP and adverse outcomes.
Main Results:
- Contradictory findings exist regarding the "J-curve" effect.
- Some analyses suggest an increased risk of coronary events or mortality at treated DBP < 80 mm Hg.
- Other evidence does not support a significant increase in adverse events at lower DBP levels.
Conclusions:
- The existence and clinical significance of the "J-curve" in hypertension management remain debated.
- A nuanced approach is necessary when determining optimal blood pressure targets.
- Further research is needed to clarify the risks and benefits of intensive blood pressure lowering.
Abstract:
Recent analyses of treated blood pressure versus events suggest that drug treatment might result in an increase in coronary events or mortality at treated diastolic pressures below 80 mm Hg (the "J-curve"). However, this contention is highly controversial. Both sides of the argument are examined and a balanced approach for target blood pressure goals on treatment is outlined.